Pharmacy Question for the Week of May 20, 2019

Pharmacy Compliance Question of the Week


What are the criteria points for EPO coverage regarding anemia patients with chronic renal failure?


Erythropoietin (EPO) is covered for the treatment of anemia for patients with chronic renal failure who are on dialysis when one of the following are true.

  • It is administered in the renal dialysis facility 
  • Or EPO is self-administered in the home by any dialysis patient (or patient caregiver) who is determined competent to use the drug and meets the other conditions specified in the Medicare Benefit Policy Manual.

Disclaimer: Every reasonable effort was made to ensure the accuracy of this information at the time it was published. However, due to the nature of industry changes over time we cannot guarantee its validity after the year it was published.